Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,328.90Prev. Close
1,318.90Volume
2,02,073Total traded value
26.79 CrUpper Circuit
1,458.60Lower Circuit
1,193.40Fundamentals
| Market Cap | ₹24,985Cr |
| ROE | 15.32% |
| P/E Ratio(TTM) | 32.46 |
| EPS(TTM) | 40.60 |
| P/B Ratio | 5.62 |
| Dividend Yield | 0.23% |
| Industry P/E | 34.63 |
| Book Value | 234.55 |
| Debt to Equity | 0.23 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Emcure Pharmaceuticals
Emcure Pharmaceuticals is a global pharmaceutical company focused on creating high-impact treatments and leveraging innovation to solve complex healthcare problems. At its core, the company's mission has always been to go beyond the cure, extending care into long-term patient empowerment and support. The company's strength is proven, with 19 of its top 20 brands ranked among the top 3 in their respective therapy areas.;
| Parent Organisation | Emcure Pharmaceuticals |
| NSE Symbol | EMCURE |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Wockhardt | NA (0.00%) | -139.73 | ||
| Concord Biotech | NA (0.00%) | 42.38 |